Skip to content

Solventum SOLV Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

3M logo
3MMMM
3B
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Cardinal Health logo
Cardinal HealthCAH
UnitedHealth Group logo
UnitedHealth GroupUNH
Align Technology logo
Align TechnologyALGN
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's common stock, shares authorized (in shares)?
Solventum (SOLV) reported common stock, shares authorized (in shares) of $750M in Q1 2026.
How has Solventum's common stock, shares authorized (in shares) changed year-over-year?
Solventum's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $750M to $750M.